R&D
Partner Content
2nd mRNA Process Development & Manufacturing Summit Europe
Enhance Speed, Purity & Scalability of Your Process Development & …
19770 items found
News
PharmStars digital health accelerator names fall 2023 grads
Eleven new digital health start-ups have graduated from PharmStars’ …
News
Spyre raises $180m to advance IBD antibody pipeline
At the start of this year, Aeglea BioTherapeutics was looking like it …
Patients
On Pfizer’s initiative to return clinical trial data to patients
The average dropout rate in clinical trials hovers at about 30%. …
News
Africa-led HIV vaccine trial ends in failure
A trial viewed as the best hope of finding an effective HIV vaccine …
News
Regeneron bids to join the BCMA bispecific camp
Regeneron has moved closer to a regulatory filing for its BCMAxCD3 …
Digital
Why pharma needs to leave digital transformation behind and embrace digital business
Historically, the pharmaceutical industry has been slow to adopt …
News
Medtronic drops $738m takeover of wearable insulin pump firm
Medtech giant Medtronic has decided not to go ahead with a planned …
News
Biden may order compulsory licensing in drug pricing move
The White House said today that it may take enforced ownership of …
R&D
Biofidelity’s ASPYRE: The future is bright for oncology
Genomic technology company Biofidelity has announced the launch of …
News
Ipsen/Genfit eye June FDA verdict for liver drug elafibranor
The FDA has kicked off a priority review of Genfit and Ipsen’s …
Patients
Bringing women’s health up to speed for 21st century human healthcare
In this latest instalment of the pharmaphorum podcast, web editor …
News
Nasdaq debutante Septerna swells its IPO to $331m
Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount raised topping $331 million.
Sales & Marketing
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
A journey from personal to public: Digital health passports ...
A digital health passport is an app, or online certification, that displays a traveller’s health or vaccination record. It can save lives, on both private and public levels.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
R&D
Partner Content
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
